Please ensure Javascript is enabled for purposes of website accessibility
REVIEW PAPER
Viscosupplementation in prevention and treatment of the degenerative joint disease
 
More details
Hide details
 
Submission date: 2015-12-01
 
 
Acceptance date: 2015-12-03
 
 
Publication date: 2016-01-11
 
 
Medical Studies 2015;31(4):300-306
 
KEYWORDS
TOPICS
ABSTRACT
Osteoarthritis (OA) is one of the most common musculoskeletal disorders. It limits patients’ functionality and life satisfaction significantly. Although there are numerous types of therapy, the success rate of conservative treatment is limited, and it is often necessary to introduce surgical treatment. Therefore, new effective methods of therapy for OA are being tested and submitted. Endogenous hyaluronic acid (HA) is a natural ingredient of many tissues in the human organism, including synovial fluid. Viscosupplementation with the usage of HA is a relatively new method for treating degenerative joint changes. By virtue of its good safety profile and simplicity of application, it is increasingly used as an alternative or addition to classic conservative treatment. In this work, we attempted to summarise the current state of knowledge of HA usage in OA treatment based on literature.
REFERENCES (67)
1.
Loeser RF. Age-related changes in the musculoskeletal system and the development of osteoarthritis. Clin Geriatr Med 2010; 26: 371-86.
 
2.
Reijman M, Pols HA, Bergink AP, et al. Body mass index associated with onset and progression of osteoarthritis of the knee but not of the hip: the Rotterdam Study. Ann Rheum Dis 2007; 66: 158-62.
 
3.
Yusuf E, Nelissen RG, Ioan-Facsinay A, et al. Association between weight or body mass index and hand osteoarthritis: a systematic review. Ann Rheum Dis 2010; 69: 761-5.
 
4.
Legré-Boyer V. Viscosupplementation: techniques, indications, results. Orthop Traumatol Surg Res 2015; 101 (1 Suppl.): S101-8.
 
5.
Abbott T, Altman RD, Dimeff R, et al. Do hyaluronic acid injections delay total knee replacement surgery? ACR 2013 Program Book (Suppl.): 308 Abstract 2139.
 
6.
Romagnoli M, Belmontesi M. Hyaluronic acid-based fillers: theory and practice. Clin Dermatol 2008; 26: 123-59.
 
7.
Sudha PN, Rose MH. Beneficial effects of hyaluronic acid. Adv Food Nutr Res 2014; 72: 137-76.
 
8.
Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol Suppl. 1993; 39: 3-9.
 
9.
Balazs EA. Therapeutic use of hyaluronan. Struct Chem 2009; 20: 341.
 
10.
Wohlrab W, Neubert R, Wohlrab J. Hyaluronsaure und Haut. In: Trends in clinical and experimental dermatology. Wohlrab J (ed.). Shaker Verlag, Aachen 2004; 5-39.
 
11.
Neustadt D, Caldwell J, Bell M, et al. Clinical effects of intraarticular injection of high molecular weight hyaluronan (Orthovisc) in osteoarthritis of the knee: a randomized, controlled, multicenter trial. J Rheumatol 2005; 32: 1928-36.
 
12.
Henrotin Y, Raman R, Richette P, et al. Consensus statement on viscosupplementation with hyaluronic acid for the management of osteoarthritis. Semin Arthritis Rheum 2015; 45: 140-9.
 
13.
Hui AY, McCarty WJ, Masuda K, et al. A systems biology approach to synovial joint lubrication in health, injury, and disease. Wiley Interdiscip Rev Syst Biol Med 2012; 4: 15-37.
 
14.
Rhee DK, Marcelino J, Baker M, et al. The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth. J Clin Invest 2005; 115: 622-31.
 
15.
Ludwig TE, McAllister JR, Lun V, et al. Diminished cartilage-lubricating ability of human osteoarthritic synovial fluid deficient in proteoglycan 4: restoration through proteoglycan 4 supplementation. Arthritis Rheum 2012; 64: 3963-71.
 
16.
Palacio LE, Vitanzo PC. Viscosupplementation. In: Minimally invasive musculoskeletal pain medicine. Freedman M, Morrison WB, Harwood MI (eds.). New York, NY: Informa Healthcare 2007; 53-67.
 
17.
Peter C, Vitanzo Jr, Barry E, et al. Nonsurgical alternatives/conservative management. In: Essentials in total knee arthroplasty. Javad Parvizi (ed.). Brian Klatt, SLACK Incorporated 2011.
 
18.
Caborn D, Rush J, Lanzer W, et al. A randomized, single-blind comparison of the efficacy and tolerability of hylan G-F 20 and triamcinolone hexacetonide in patients with osteoarthritis of the knee. J Rheumatol 2004; 31: 333-43.
 
19.
George E. Intra-articular hyaluronan treatment for osteoarthritis. Ann Rheum Dis 1998; 57: 637-40.
 
20.
Brandt KD, Smith GN Jr, Simon LS. Intraarticular injection of hyaluronan as the treatment for knee osteoarthritis: what is the evidence? Arthritis Rheum 2000; 43: 1192-203.
 
21.
Guidolin DD, Ronchetti IP, Lini E, et al. Morphological analysis of articular cartilage biopsies from a randomized, clinical study comparing the effects of 500-730 kDa sodium hyaluronate (Hyalgan) and methylprednisolone acetate on primary osteoarthritis of the knee. Osteoarthritis Cartilage 2001; 9: 371-81.
 
22.
Moreland LW. Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis Res Ther 2003; 5: 54-67.
 
23.
Zhang W, Doherty M, Leeb BF, et al. EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007; 66: 377-88.
 
24.
Berenbaum F, Grifka J, Cazzaniga S, et al. A randomised, double-blind, controlled trial comparing two intra-articular hyaluronic acid preparations differing by their molecular weight in symptomatic knee osteoarthritis. Ann Rheum Dis 2012; 71: 1454-60.
 
25.
Agerup B, Berg P, Akermark C. Non-animal stabilized hyaluronic acid: a new formulation for the treatment of osteoarthritis. BioDrugs 2005; 19: 23-30.
 
26.
Conrozier T. Optimizing the effectiveness of viscosupplementation in non-knee osteoarthritis. Joint Bone Spine 2015 Oct 6. pii: S1297-319X(15)00180-3. doi: 10.1016/j.jbspin.2015.08.009.
 
27.
Roux CH, Euller-Ziegler L, Injections for treatment of carpometacarpal osteoarthritis (rhizarthrosis): what is the evidence? Joint Bone Spine 2015 Oct 6. pii: S1297-319X(15)00167-0. doi: 10.1016/j.jbspin.2015.04.012.
 
28.
Leopold SS, Warme WJ, Pettis PD, et al. Increased frequency of acute local reaction to intra-articular hylan GF-20 (synvisc) in patients receiving more than one course of treatment. J Bone Joint Surg Am 2002; 84-A: 1619-23.
 
29.
Bertucci V, Lynde CB. Current concepts in the use of small-particle hyaluronic acid. Plast Reconstr Surg 2015; 136 (5 Suppl.): 132S-8S.
 
30.
Greene JJ, Sidle DM. The hyaluronic acid fillers: current understanding of the tissue device interface. Facial Plast Surg Clin North Am 2015; 23: 423-32.
 
31.
Cam C, Zhu S, Truong NF, et al. Systematic evaluation of natural scaffolds in cutaneous wound healing. J Mater Chem B Mater Biol Med 2015; 3: 7986-92.
 
32.
Hancı D, Altun H. Effectiveness of hyaluronic acid in post-tonsillectomy pain relief and wound healing: a prospective, double-blind, controlled clinical study. Int J Pediatr Otorhinolaryngol 2015; 79: 1388-92.
 
33.
Sayin I, Kaya KH, Ekizoğlu O, et al. A prospective controlled trial comparing spontaneous closure and Epifilm® patching in traumatic tympanic membrane perforations. Eur Arch Otorhinolaryngol 2013; 270: 2857-63.
 
34.
Bruyère O, Cooper C, Pelletier JP, et al. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Semin Arthritis Rheum 2014; 44: 253-63.
 
35.
Moreland LW. Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis Res Ther 2003; 5: 54e67.
 
36.
Hochberg MC, Altman RD, April KT, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res 2012; 64: 465-74.
 
37.
Brown GA. AAOS clinical practice guideline: treatment of osteoarthritis of the knee: evidence-based guideline, 2nd ed. J Am Acad Orthop Surg 2013; 21: 577-9.
 
38.
Chevalier X. Viscosupplémentation. e-Mem Acad Natl Chir 2012; 11: 040-3.
 
39.
Rutjes AW, Jüni P, da Costa BR, et al. Viscosupplementation for osteoarthritis of the knee: a systematic review and meta-analysis. Ann Intern Med 2012; 157: 180-91.
 
40.
Wang CT, Lin J, Chang CJ, et al. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg Am 2004; 86-A: 538e45.
 
41.
Bellamy N, Campbell J, Robinson V, et al. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2006; 2: CD005321.
 
42.
Lo GH, LaValley M, McAlindon T, et al. Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a metaanalysis. JAMA 2003; 290: 3115e21.
 
43.
Modawal A, Ferrer M, Choi HK, et al. Hyaluronic acid injections relieve knee pain. J Fam Pract 2005; 54: 758e67.
 
44.
Bannuru RR, Natov NS, Dasi UR, et al. Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis: meta-analysis. Osteoarthritis Cartilage 2011; 19: 611-9.
 
45.
Towheed TE, Maxwell L, Judd MG, et al. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev 2006; 1: CD004257.
 
46.
Zhang W, Nuki G, Moskowitz RW, et al. OARSI recommendations for the management of hip and knee osteoarthritis Part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage 2010; 18: 476e99.
 
47.
Lee C, Hunsche E, Balshaw R, et al. Need for common internal controls when assessing the relative efficacy of pharmacologic agents using a meta-analytic approach: case study of cyclooxygenase 2-selective inhibitors for the treatment of osteoarthritis. Arthritis Rheum 2005; 53: 510e8.
 
48.
Arrich J, Piribauer F, Mad P, et al. Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and metaanalysis. CMAJ 2005; 172: 1039e43.
 
49.
Medina JM, Thomas A, Denegar CR. Knee osteoarthritis: should your patient opt for hyaluronic acid injection? J Fam Pract 2006; 55: 669e75.
 
50.
Bannuru RR, Vaysbrot EE, Sullivan MC, et al. Relative efficacy of hyaluronic acid in comparison with NSAIDs for knee osteoarthritis: a systematic review and meta-analysis. Semin Arthritis Rheum 2014; 43: 593-9.
 
51.
Campbell J, Bellamy N, Gee T. Differences between systematic reviews/meta-analyses of hyaluronic acid/hyaluronan/hylan in osteoarthritis of the knee. Osteoarthritis Cartilage 2007; 15: 1424-36.
 
52.
Noël E, Hardy P, Hagena FW, et al. Efficacy and safety of Hylan G-F 20 in shoulder osteoarthritis with an intact rotator cuff. Open-label prospective multicenter study. Joint Bone Spine 2009; 76: 670-3.
 
53.
Kwon YW, Eisenberg G, Zuckerman JD. Sodium hyaluronate for the treatment of chronic shoulder pain associated with glenohumeral osteoarthritis: a multicenter, randomized, double-blind, placebo-controlled trial. J Shoulder Elbow Surg 2013; 22: 584-94.
 
54.
Blaine T, Moskowitz R, Udell J, et al. Treatment of persistent shoulder pain with sodium hyaluronate: a randomized, controlled trial. A multicenter study. J Bone Joint Surg Am 2008; 90: 970-9.
 
55.
Colen S, Geervliet P, Haverkamp D, et al. Intra-articular infiltration therapy for patients with glenohumeral osteoarthritis: a systematic review of the literature. Int J Shoulder Surg 2014; 8: 114-21.
 
56.
Colen S, Haverkamp D, Mulier M, et al. Hyaluronic acid for the treatment of osteoarthritis in all joints except the knee: what is the current evidence? BioDrugs 2012; 26: 101-12.
 
57.
Manara M, Bortoluzzi A, Favero M, et al. Italian Society for Rheumatology recommendations for the management of hand osteoarthritis. Reumatismo 2013; 65: 167-85.
 
58.
Fuchs S, Mönikes R, Wohlmeiner A, et al. Intra-articular hyaluronic acid compared with corticoid injections for the treatment of rhizarthrosis. Osteoarthritis Cartilage 2006; 14: 82-8.
 
59.
Trellu S, Dadoun S, Berenbaum F, et al. Intra-articular injections in tumb osteoarthritis: systematic review and meta-analysis of randomized controlled trials. Joint Bone Spine 2015, http://dx.doi.org/10.1016/j.jb....
 
60.
Roux CH, Euller-Ziegler L. Injections for treatment of carpometacarpal osteoarthritis (rhizarthrosis): what is the evidence? Joint Bone Spine 2015 Oct 6. pii: S1297-319X(15)00167-0. doi: 10.1016/j.jbspin.2015.04.012.
 
61.
Conrozier T, Couris CM, Mathieu P, et al. Safety, efficacy and predictive factors of efficacy of a single intra-articular injection of non-animal-stabilized hyaluronic acid in the hip joint: results of a standardized follow-up of patient treated for hip osteoarthritis in daily practice. Arch Orthop Trauma Surg 2009; 129: 843-8.
 
62.
Atchia I, Kane D, Reed MR, et al. Efficacy of a single ultrasound-guided injection for the treatment of hip osteoarthritis. Ann Rheum Dis 2011; 70: 110-6.
 
63.
Fernández López JC, Ruano-Ravina A. Efficacy and safety of intraarticular hyaluronic acid in the treatment of hip osteoarthritis: a systematic review. Osteoarthritis Cartilage 2006; 14: 1306-11.
 
64.
Qvistgaard E, Christensen R, Torp-Pedersen S, et al. Intra-articular treatment of hip osteoarthritis: a randomized trial of hyaluronic acid, corticosteroid, and isotonic saline. Osteoarthritis Cartilage 2006; 14: 163-70.
 
65.
Rivera F. Single intra-articular injection of high molecular weight hyaluronic acid for hip osteoarthritis. J Orthop Traumatol 2015 Oct 8. [Epub ahead of print].
 
66.
Sun SF, Chou YJ, Hsu CW, et al. Efficacy of intra-articular hyaluronic acid in patients with osteoarthritis of the ankle: a prospective study. Osteoarthritis Cartilage 2006; 14: 867-74.
 
67.
Witteveen AG, Hofstad CJ, Kerkhoffs GM. Hyaluronic acid and other conservative treatment options for osteoarthritis of the ankle. Cochrane Database Syst Rev 2015; 10: CD010643.
 
eISSN:2300-6722
ISSN:1899-1874
Journals System - logo
Scroll to top